These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23866665)

  • 1. [Meta-analysis of association between E-cadherin promoter methylation and lung cancer risk].
    Zeng Y; Liu R; Zhang H
    Zhongguo Fei Ai Za Zhi; 2013 Jul; 16(7):353-8. PubMed ID: 23866665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E-cadherin gene methylation in lung cancer.
    Liu ZL; Wang Q; Huang LN
    Tumour Biol; 2014 Sep; 35(9):9027-33. PubMed ID: 24906605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter methylation and polymorphism of E-cadherin gene may confer a risk to prostate cancer: a meta-analysis based on 22 studies.
    Chang Z; Zhou H; Liu Y
    Tumour Biol; 2014 Oct; 35(10):10503-13. PubMed ID: 25056535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assessment of the diagnostic role of CDH13 promoter methylation in lung cancer.
    Zhong YH; Peng H; Cheng HZ; Wang P
    Asian Pac J Cancer Prev; 2015; 16(3):1139-43. PubMed ID: 25735345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does hypermethylation of CpG island in the promoter region of the E-cadherin gene increase the risk of lung cancer? A meta-analysis.
    Sun Z; Liu G; Xu N
    Thorac Cancer; 2019 Jan; 10(1):54-59. PubMed ID: 30390382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features.
    Kim DS; Kim MJ; Lee JY; Kim YZ; Kim EJ; Park JY
    Cancer; 2007 Dec; 110(12):2785-92. PubMed ID: 17960794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between CDH1 promoter methylation and patients with ovarian cancer: a systematic meta-analysis.
    Wang Q; Wang B; Zhang YM; Wang W
    J Ovarian Res; 2016 Apr; 9():23. PubMed ID: 27067410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-cadherin gene promoter hypermethylation may contribute to the risk of bladder cancer among Asian populations.
    Li G; Liu Y; Yin H; Zhang X; Mo X; Tang J; Chen W
    Gene; 2014 Jan; 534(1):48-53. PubMed ID: 24404589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant promoter methylation of the CHD1 gene may contribute to the pathogenesis of breast cancer: a meta-analysis.
    Gu X; Xue JQ; Zhu X; Ye MS; Zhang WH
    Tumour Biol; 2014 Sep; 35(9):9395-404. PubMed ID: 24952891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant Methylation of T-cadherin Can Be a Diagnostic Biomarker for Colorectal Cancer.
    Duan BS; Xie LF; Wang Y
    Cancer Genomics Proteomics; 2017; 14(4):277-284. PubMed ID: 28647701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Systematic Analysis of the Relationship of CDH13 Promoter Methylation and Breast Cancer Risk and Prognosis.
    Yang J; Niu H; Huang Y; Yang K
    PLoS One; 2016; 11(5):e0149185. PubMed ID: 27153114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant methylation of H-cadherin (CDH13) promoter is associated with tumor progression in primary nonsmall cell lung carcinoma.
    Kim JS; Han J; Shim YM; Park J; Kim DH
    Cancer; 2005 Nov; 104(9):1825-33. PubMed ID: 16177988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of E-cadherin methylation with risk of nasopharyngeal cancer: A meta-analysis.
    Wu C; Peng S; Sun W; Luo M; Su B; Liu D; Hu G
    Head Neck; 2018 Nov; 40(11):2538-2545. PubMed ID: 29947108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of RASSF1A promoter methylation with lung cancer risk: a meta-analysis.
    Huang YZ; Wu W; Wu K; Xu XN; Tang WR
    Asian Pac J Cancer Prev; 2014; 15(23):10325-8. PubMed ID: 25556469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes of downregulation of E-cadherin gene expression in non-small cell lung cancer.
    Zheng SY; Hou JY; Zhao J; Jiang D; Ge JF; Chen S
    Asian Pac J Cancer Prev; 2012; 13(4):1557-61. PubMed ID: 22799366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer.
    Wang G; Hu X; Lu C; Su C; Luo S; Luo ZW
    Lung Cancer; 2008 Nov; 62(2):162-72. PubMed ID: 18468719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of aberrant Wnt7a promoter methylation in human non-small cell lung cancer in Koreans.
    Kim TH; Moon JY; Kim SH; Paik SS; Yoon HJ; Shin DH; Park SS; Sohn JW
    J Korean Med Sci; 2015 Feb; 30(2):155-61. PubMed ID: 25653486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma.
    Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ
    Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of RASSF1A promoter methylation with gastric cancer risk: a meta-analysis.
    Shi DT; Han M; Gao N; Tian W; Chen W
    Tumour Biol; 2014 Feb; 35(2):943-8. PubMed ID: 23982879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.
    Caldeira JR; Prando EC; Quevedo FC; Neto FA; Rainho CA; Rogatto SR
    BMC Cancer; 2006 Mar; 6():48. PubMed ID: 16512896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.